sofidexFor patientsAre you a clinician? Clinical site

Meds & supplements  ›  Levorphanol

Medicine

Levorphanol

Levorphanol Tartrate Tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for
Levorphanol Tartrate Tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Do not take if
  • Significant respiratory depression ( see WARNINGS )
  • Acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment ( see WARNINGS )
  • Known or suspected gastrointestinal obstruction, including paralytic ileus ( see WARNINGS )
  • Hypersensitivity to levorphanol or any of the formulation excipients (e.g., anaphylaxis) ( see WARNINGS ).

Side effects, and when to stop

In approximately 1400 patients treated with Levorphanol Tartrate Tablets in controlled clinical trials, the type and incidence of side effects were those expected of an opioid analgesic, and no unforeseen or unusual toxicity was reported.

Drugs of this type are expected to produce a cluster of typical opioid effects in addition to analgesia, consisting of nausea, vomiting, altered mood and mentation, pruritus, flushing, difficulties in urination, constipation, and biliary spasm. The frequency and intensity of these effects appears to be dose related. Although listed as adverse events these are expected pharmacologic actions of these drugs and should be interpreted as such by the clinician.

The following adverse events have been reported with the use of Levorphanol Tartrate Tablets:

Body as a Whole: abdominal pain, dry mouth, sweating

Cardiovascular System: cardiac arrest, shock, hypotension, arrhythmias including bradycardia and tachycardia, palpitations, extra-systoles

Digestive System: nausea, vomiting, dyspepsia, biliary tract spasm

Nervous System: coma, suicide attempt, convulsions, depression, dizziness, confusion, lethargy, abnormal dreams, abnormal thinking, nervousness, drug withdrawal, hypokinesia, dyskinesia,

hyperkinesia, CNS stimulation, personality disorder, amnesia, insomnia Respiratory System: apnea, cyanosis, hypoventilation

Skin & Appendages: pruritus, urticaria, rash, injection site reaction

Special Senses: abnormal vision, pupillary disorder, diplopia

Urogenital System: kidney failure, urinary retention, difficulty urinating

Who should not take it

Levorphanol Tartrate Tablets are contraindicated in patients with:

  • Significant respiratory depression ( see WARNINGS )
  • Acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment ( see WARNINGS )
  • Known or suspected gastrointestinal obstruction, including paralytic ileus ( see WARNINGS )
  • Hypersensitivity to levorphanol or any of the formulation excipients (e.g., anaphylaxis) ( see WARNINGS ).

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Levorphanol; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/levorphanol

APA 7th

sofidex. (2026, August 3). Levorphanol. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/levorphanol

AMA 11th

Levorphanol. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/levorphanol

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.